Cargando…
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection
Previous work examining the therapeutic efficacy of adjunct thymosin beta 4 (Tβ4) to ciprofloxacin for ocular infectious disease has revealed markedly reduced inflammation (inflammatory mediators and innate immune cells) with increased activation of wound healing pathways. Understanding the therapeu...
Autores principales: | Wang, Yuxin, Carion, Thomas W., Ebrahim, Abdul Shukkur, Sosne, Gabriel, Berger, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700181/ https://www.ncbi.nlm.nih.gov/pubmed/34944086 http://dx.doi.org/10.3390/cells10123579 |
Ejemplares similares
-
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis
por: Wang, Yuxin, et al.
Publicado: (2021) -
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis
por: Carion, Thomas W., et al.
Publicado: (2020) -
Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis
por: Carion, Thomas W, et al.
Publicado: (2018) -
A Novel Combination Therapy Tβ4/VIP Protects against Hyperglycemia-Induced Changes in Human Corneal Epithelial Cells
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2023) -
Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent
por: Sosne, Gabriel, et al.
Publicado: (2007)